Page results
-
The Royal London Hospital for Integrated Medicine (RLHIM) is a centre for evidence-based practice, education and research, specialising in chronic and complex medical conditions.
-
Digital accessibility and sustainability drive a switch to online patient information at UCLH
-
You can use MyCare on your mobile, tablet or computer to securely view and manage information about your health and care at UCLH.
-
The rhinology unit covers all aspects of nose and sinus disease including allergy, infection, inflammatory/mucosal conditions, breathing disorders and tumours.
-
Online form for beginning the sefl referral process at UCLH maternity services.
-
The FGM service provides consultations, assessments, and support and referral to other services where clinically indicated
-
We offer weekly neuro-rehabilitation assessment clinics where our patients are assessed by a multidisciplinary team.
-
The Dermatology Department at University College Hospital is located in the Mortimer Market Centre and is housed in a newly refurbished dedicated skin clinic area where we see all of our adult patients for their outpatient appointments as well as surgical procedures and phototherapy.
-
This page provides an overview of the Ambulatory Care Service for adult patients.
-
Radiotherapy Department Patient Information series no. 18 - prostate brachytherapy prostate high dose rate (HDR) brachytherapy
File results
-
FOI/2024/0692 - Integrated Care Board (ICB) expenditure sign-off process 2023/24
-
FOI/2024/0693 - Patients overhead or ceiling track hoists portable/ mobile hoists installed
-
FOI/2024/0695 - Air filtration used/ air exchange rate across Trust
-
FOI/2024/0696 - Various IT systems used at Trust
-
FOI/2024/0704 - Contingencies to support visitors/ patients/ contractors witnessing a distressing event
-
FOI/2024/0712 - Occupational health services, spend/ in-house/ outsourced 2021/22-2023/24
-
FOI/2024/0709 - Number of dilation and curettage operations for miscarriages 2019-2024
-
FOI/2024/0687 - Newly diagnosed patients with AML starting first line treatment - February-July 2024
-
FOI/2024/0703 - Neurofibromatosis type 1 treatment/ volume of medication dispensed
-
FOI/2024/0702 - Community respiratory service mapping/ community-based bronchiectasis services